These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34493184)

  • 21. The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology.
    Doifode T; Giridharan VV; Generoso JS; Bhatti G; Collodel A; Schulz PE; Forlenza OV; Barichello T
    Pharmacol Res; 2021 Feb; 164():105314. PubMed ID: 33246175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
    Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
    Seo DO; Holtzman DM
    Exp Mol Med; 2024 Feb; 56(1):86-94. PubMed ID: 38172602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview.
    Giridharan VV; Barichello De Quevedo CE; Petronilho F
    Neurosci Res; 2022 Aug; 181():17-21. PubMed ID: 35577241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    Shen L; Liu L; Ji HF
    J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota Composition Is Related to AD Pathology.
    Verhaar BJH; Hendriksen HMA; de Leeuw FA; Doorduijn AS; van Leeuwenstijn M; Teunissen CE; Barkhof F; Scheltens P; Kraaij R; van Duijn CM; Nieuwdorp M; Muller M; van der Flier WM
    Front Immunol; 2021; 12():794519. PubMed ID: 35173707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review.
    Yin JT; Xu XW; Jin CY; Yuan XY; Wang XG
    J Integr Neurosci; 2023 Feb; 22(2):38. PubMed ID: 36992601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential.
    Qu L; Li Y; Liu F; Fang Y; He J; Ma J; Xu T; Wang L; Lei P; Dong H; Jin L; Yang Q; Wu W; Sun D
    Aging Dis; 2024 May; 15(3):1108-1131. PubMed ID: 37728579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. d-glutamate and Gut Microbiota in Alzheimer's Disease.
    Chang CH; Lin CH; Lane HY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
    Wang Y; Dykes GA
    CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
    Daily JW; Kang S; Park S
    Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota and Immunotherapy for Alzheimer's Disease.
    Dai CL; Liu F; Iqbal K; Gong CX
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Kowalski K; Mulak A
    J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation.
    Lekchand Dasriya V; Samtiya M; Dhewa T; Puniya M; Kumar S; Ranveer S; Chaudhary V; Vij S; Behare P; Singh N; Aluko RE; Puniya AK
    J Food Biochem; 2022 Jan; 46(1):e14043. PubMed ID: 34927261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report.
    Hazan S
    J Int Med Res; 2020 Jun; 48(6):300060520925930. PubMed ID: 32600151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    Li Z; Zhu H; Guo Y; Du X; Qin C
    J Neurochem; 2020 Nov; 155(4):448-461. PubMed ID: 32319677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary Pattern, Gut Microbiota, and Alzheimer's Disease.
    Zhang M; Zhao D; Zhou G; Li C
    J Agric Food Chem; 2020 Nov; 68(46):12800-12809. PubMed ID: 32090565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.